W. Lam

J. Lipton, A. Viswabandya, H. Messner, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comorbidity profile of adult survivors at 20 years following allogeneic hematopoietic cell transplantation

J. Lipton, F. Michelis, W. Lam, 2020, European journal of haematology.

Impact of hematopoietic cell transplant frailty scale on transplant outcome in adults

J. Lipton, A. Viswabandya, S. Alibhai, 2022, Bone Marrow Transplantation.

Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantation

J. Lipton, A. Viswabandya, M. Remberger, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Post-transplant cyclophosphamide combined with anti-thymocyte globulin for graft-vs-host disease prophylaxis improves survival and lowers non-relapse mortality in older patients undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2020, Annals of Hematology.

Low rates of acute and chronic GVHD with ATG and PTCy in matched and mismatched unrelated donor peripheral blood stem cell transplants

A. Viswabandya, E. Atenafu, A. Law, 2019, European journal of haematology.

Safety and Efficacy of Haploidentical Peripheral Blood Stem Cell Transplantation for Myeloid Malignancies Using Post-transplantation Cyclophosphamide and Anti-thymocyte Globulin as Graft-versus-Host Disease Prophylaxis

J. Lipton, A. Viswabandya, J. Mattsson, 2019, Clinical hematology international.

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

J. Lipton, A. Viswabandya, H. Messner, 2018, Biology of Blood and Marrow Transplantation.

Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti‐thymocyte globulin myeloablative conditioning

J. Storek, Haocheng Li, A. Daly, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Bone Marrow Transplantation.

Sequential liver and haematopoietic stem cell transplantation in a case of fulminant hepatitis associated liver failure and aplastic anaemia

J. Lipton, L. Lilly, Z. Galvin, 2019, European journal of haematology.

Fresh vs. frozen allogeneic peripheral blood stem cell grafts: A successful timely option

J. Lipton, A. Viswabandya, J. Mattsson, 2020, American journal of hematology.

Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2019, European journal of haematology.

Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.

Comparison of outcomes after second allogeneic hematopoietic cell transplantation versus donor lymphocyte infusion in allogeneic hematopoietic cell transplant patients

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Clinical Lymphoma Myeloma and Leukemia.

Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant

J. Lipton, A. Viswabandya, E. Atenafu, 2020, European journal of haematology.

Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Bone Marrow Transplantation.

Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Transplantation and cellular therapy.

Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections

J. Lipton, A. Viswabandya, E. Atenafu, 2021, Leukemia & lymphoma.

IMPROVING SAFETY AND OUTCOMES AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: A SINGLE-CENTRE EXPERIENCE.

J. Lipton, A. Viswabandya, M. Remberger, 2022, Transplantation and cellular therapy.

Comparison of the Prognostic Ability of the HCT-CI, the Modified EBMT, and the EBMT-ADT Pre-transplant Risk Scores for Acute Leukemia.

J. Lipton, A. Viswabandya, S. Cyriac, 2021, Clinical lymphoma, myeloma & leukemia.

Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: a Single-Center Study.

J. Lipton, A. Viswabandya, M. Remberger, 2021, Transplantation and cellular therapy.

Outcomes of patients diagnosed with chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation: Results from a tertiary care center.

J. Lipton, A. Viswabandya, J. Mattsson, 2021, Hematology/oncology and stem cell therapy.

Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experience

J. Lipton, A. Viswabandya, I. Novitzky-Basso, 2023, Annals of Hematology.

MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.

L. Waldron, R. Gascoyne, L. Sehn, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pilot prospective study of Frailty and Functionality in routine clinical assessment in allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Bone Marrow Transplantation.

High incidence but low mortality of EBV-reactivation and PTLD after alloHCT using ATG and PTCy for GVHD prophylaxis

Deepali Kumar, J. Lipton, A. Viswabandya, 2020, Leukemia & lymphoma.

Prolactin, a potential biomarker for chronic GVHD activity

S. Ezzat, J. Lipton, A. Viswabandya, 2020, European journal of haematology.

Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term Complications.

J. Lipton, A. Viswabandya, E. Atenafu, 2020, Blood cell therapy.

The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia

C. Andrews, H. Sibai, W. Lam, 2020, Leukemia & lymphoma.

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

M. Minden, Zhaolei Zhang, Steven M. Chan, 2021, Bone Marrow Transplantation.

Risk factors for graft failure in allogeneic hematopoietic stem cell transplantation: a single-center study

A. Viswabandya, M. Remberger, J. Lipton, 2020, Cellular Therapy and Transplantation.

Anti‐thymocyte Globulin and Post‐Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen‐A and ‐B mismatched donors

J. Lipton, A. Viswabandya, M. Remberger, 2021, European journal of haematology.

Moderate-severe grade of chronic graft versus host disease and younger age (less than 45 years old) are risk factors for avascular necrosis in adult patients undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, S. Bhella, 2015, Annals of Hematology.

Dual T Cell Depletion with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-Hematopoietic Stem Cell Transplantation

A. Viswabandya, A. Law, W. Lam, 2019 .

A unique case of tuberculosis dissemination presenting as cutaneous lesions in a post allogeneic stem cell transplant patient

J. Lipton, A. Viswabandya, H. Messner, 2016, Bone Marrow Transplantation.

Refined hepatic grading system in chronic graft‐versus‐host disease improves prognostic risk stratification of long‐term outcomes

J. Lipton, A. Viswabandya, J. Mattsson, 2021, European journal of haematology.

Dual T-cell Depletion with ATG and PTCy Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-HSCT.

A. Viswabandya, A. Law, W. Lam, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Progressive Multifocal Leukoencephalopathy due to John Cunningham (JC) virus following Allogeneic Haematopoietic Cell Transplantation

Deepali Kumar, J. Lipton, A. Viswabandya, 2017, Antiviral therapy.

Clonal hematopoiesis in the donor does not adversely affect long-term outcomes following allogeneic hematopoietic stem cell transplantation: result from a 13-year follow-up

T. Biezuner, Zhaolei Zhang, J. Lipton, 2023, Haematologica.

Interaction between High-Dose Intravenous Busulfan and Post-Transplant Cyclophosphamide on Hemorrhagic Cystitis after Allogeneic Hematopoietic Cell Transplantation.

J. Lipton, A. Viswabandya, T. Mazzulli, 2023, Transplantation and cellular therapy.

Allogeneic Stem Cell Transplantation Has Limited Benefit in Older Patients with Mixed Phenotype Acute Leukemia

M. Minden, Steven M. Chan, J. Lipton, 2019, Biology of Blood and Marrow Transplantation.

Mutational profile, outcomes, and impact of allogeneic hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia and inconclusive cytogenetic analysis

M. Minden, Steven M. Chan, J. Lipton, 2023, European journal of haematology.

ATG-Ptcy-CSA for Gvhd Prevention in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation for Adults with Hematological Malignancies

J. Lipton, A. Viswabandya, E. Atenafu, 2022, Blood.

Ptcy-ATG-CSA Vs. ATG-MMF-CSA for Gvhd Prevention for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

J. Lipton, A. Viswabandya, E. Atenafu, 2022, Blood.

Prognostic implication of pre-transplant FEV1 on long-term outcomes following allogeneic hematopoietic stem cell transplantation.

J. Lipton, A. Viswabandya, T. Marras, 2023, European journal of haematology.

Propensity score matching analysis comparing the efficacy and steroid tapering benefit of extracorporeal photopheresis to best available therapy in third-line or beyond treatment for chronic GvHD.

A. Viswabandya, Christopher J. Patriquin, I. Novitzky-Basso, 2023, Transplantation and cellular therapy.

Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure.

A. Viswabandya, Christopher J. Patriquin, I. Novitzky-Basso, 2023, Leukemia research.

Influence of conditioning regimen intensity on outcomes post‐allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remission

J. Lipton, A. Viswabandya, M. Remberger, 2023, European journal of haematology.

J. Lipton, A. Viswabandya, S. Bhella, 2021, Annals of Hematology.

HCT frailty scale for younger and older adults undergoing allogeneic hematopoietic cell transplantation

J. Lipton, A. Viswabandya, S. Alibhai, 2023, Bone Marrow Transplantation.

Outcomes of ATG-PTCY-CSA vs. ATG-based Prophylaxis for 10/10 HLA Matched Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: ATG-PTCY-CsA for PB MUD allo-HCT.

A. Viswabandya, E. Atenafu, I. Novitzky-Basso, 2024, Transplantation and cellular therapy.

Dual T cell depletion for graft versus host disease prevention in peripheral blood haploidentical hematopoietic cell transplantation for adults with hematological malignancies.

A. Viswabandya, E. Atenafu, A. Law, 2024, Bone marrow transplantation.

Choosing between older matched sibling donor and younger matched unrelated donor in allogeneic hematopoietic cell transplantation: comparison of clinical outcomes in acute myeloid leukemia and myelodysplastic syndrome.

J. Lipton, A. Viswabandya, M. Remberger, 2023, Transplantation and cellular therapy.